According to RVL Pharmaceuticals's latest financial reports the company's current revenue (TTM) is NZ$59.67 M. In 2022 the company made a revenue of NZ$78.31 M an increase over the revenue in the year 2021 that were of NZ$59.05 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.